• COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION

This section hosts guidelines, manuals and toolkits to strengthen public health practice.

Resources

FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E

EXPLORE DATA
VISUALIZATIONS

Explore key data on health and its determinants in India through interactive graphs.

COVID-19 Outbreak in India: Strategy to Contain the Pandemic

29 Jul 2022
Emerging Pandemics

by Journal of Dental & Oro-facial Research 30 MIN READ

Abstract 

Novel Coronavirus was initially proclaimed as the causal agent of pneumonia of unknown etiology in Wuhan city, China. The genome sequences have its place in the subfamily corona virinae. The current epidemic status quo of coronavirus disease-19 (COVID-19) still endured being unadorned. Since December 2019, more than 20 lakh confirmed cases and more than 1.26 lakh deaths have been reported all around the world. The fatality rate of COVID-19 was found to be 0.09% to 9.84%. In spite of being the second most populous country, coronavirus infection rate in India is low relative to population size. Countries with early implementation of comprehensive public health measures like identification, testing and isolation of cases, contact tracing and quarantine of contacts, physical distancing and “shut downs” or “lockdowns” have limited the spread of coronavirus. This review ensembles the disease surveillance around world and within Indian states. To the authors knowledge this is the first draft edifying various successful effective models of Indian states to curb this menace. A collective effort by various sectors under government supervision can help to fight the virus and flatten the curve. The study concludes  in spite of being the second most populous country, COVID-19 infection rate in India is low relative to population size. During this pandemic whole world is conducting research for possible drugs to treat the infection and for effective vaccine to make us immune to the COVID-19 infection. 

To read the full report, click on the linked file. 

Related File :

1834274808.pdf

Categories

COVID-19

RELATED
CONTENT

COVID-19

Financial Burden and Catastrophic Health Expenditure Associated with COVID-19 Ho...

A cross-sectional study to primarily estimate the Out of Pocket (OOP) expenditur...

by Clinico Economics an... 30 MIN READ

Emerging Pandemics
KEY ORGANIZATIONS
Connect with Us
Subscribe to the Newsletter

FOLLOW US

  • HOME
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
  • LEARNING LIBRARY
  • DATA VISUALIZATION
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2025 Swasti Health Catalyst

Subscribe to the Newsletter

Submit Feedback

  • COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION